The United States maintains its lead in the global R&D budget for health and society with $40.49 billion PPP, contributing significantly, though its growth is slow at 0.38%. Germany and South Korea show robust growth rates of 5.35% and 5.16% respectively. Hungary and Iceland lead with double-digit growth, reflecting dynamic developments. Conversely, Romania and Lithuania face declines surpassing 10%, indicating difficulties in maintaining momentum. The funded budgets in many European countries display strong cohesion and focus on improving healthcare development trajectories.
Future trends to watch include technological advancements and health sector digital transformations, particularly in developed countries. Emerging markets may pivot towards increased funding to improve healthcare infrastructure and outcomes, aligning with global health challenges and innovations in digitization and sustainable healthcare practices.
Top countries in R&D Budget for Health and Society by Country
| # | 10 Countries | Million US Dollars PPP, Constant | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 40,490 | 2023 | +3.59% | +0.38% | View data |
| 2 | 2 Germany | 10,240 | 2023 | +4.07% | +5.35% | View data |
| 3 | 3 Japan | 5,520 | 2023 | +2.42% | +19.52% | View data |
| 4 | 4 United Kingdom | 4,940 | 2023 | +2.45% | +3.24% | View data |
| 5 | 5 South Korea | 4,690 | 2023 | +3.5% | +5.16% | View data |
| 6 | 6 France | 4,070 | 2023 | -1.19% | +4.63% | View data |
| 7 | 7 Italy | 3,190 | 2023 | +2.3% | +9.4% | View data |
| 8 | 8 Netherlands | 2,640 | 2023 | +3.83% | +7.33% | View data |
| 9 | 9 Taiwan | 2,390 | 2023 | +2.93% | +2.16% | View data |
| 10 | 10 Australia | 1,230 | 2023 | +1.53% | +3.87% | View data |
